The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma

被引:46
作者
FitzGerald, JM
Grunfeld, A
Pare, PD
Levy, RD
Newhouse, MT
Hodder, R
Chapman, KR
Abboud, R
Lange, B
Bai, T
Etherington, J
Nolan, A
Haegert, J
Innes, G
Shustack, A
Walker, A
Cummings, G
Bowie, D
McLeod, R
Sinclair, D
Bourbeau, J
Rouleau, M
Lachance, A
Levy, R
Ducharme, J
Olivenstein, R
Martin, J
McCormack, D
Eisenhauer, M
George, C
Amer, E
Fowler, S
Ahuja, J
Stiell, I
Colohan, D
Daya, M
McCallum, A
Newhouse, M
机构
[1] ST PAULS HOSP,VANCOUVER,BC V6Z 1Y6,CANADA
[2] ROYAL COLUMBIAN HOSP,VANCOUVER,BC,CANADA
[3] ROYAL ALEXANDRA HOSP,EDMONTON,AB,CANADA
[4] VICTORIA GEN HOSP,HALIFAX,NS B3H 2Y9,CANADA
[5] HOP ST SACREMENT,MONTREAL,PQ,CANADA
[6] ROYAL VICTORIA HOSP,MONTREAL,PQ H3A 1A1,CANADA
[7] MONTREAL CHEST HOSP,MONTREAL,PQ,CANADA
[8] VICTORIA HOSP,LONDON,ON N6A 4G5,CANADA
[9] CREDIT VALLEY HOSP,MISSISSAUGA,ON,CANADA
[10] OTTAWA CIVIC HOSP,OTTAWA,ON K1Y 4E9,CANADA
[11] TORONTO HOSP,WESTERN DIV,TORONTO,ON M5T 2S8,CANADA
[12] ST JOSEPHS HOSP,HAMILTON,ON,CANADA
关键词
acute asthma; bronchodilator therapy; ipratropium bromide; salbutamol;
D O I
10.1378/chest.111.2.311
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The role of ipratropium bromide as adjunct therapy to beta-agonists in acute asthma is uncertain. We therefore decided to compare the use of 3 mg of salbutamol sulfate alone vs 3 mg salbutamol sulfate with 0.5 mg ipratropium bromide in patients with acute asthma, Patients presenting with acute asthma and an FEV(1) less than 70% predicted were randomized to a single combination treatment vs salbutamol alone, All patients received supplemental oxygen and methylprednisolone, 125 mg, IV. Baseline measurements were repeated at 45 and 90 min and these included spirometry, oximetry, and vital signs, A total of 952 patients were screened of whom 342 patients were deemed eligible and were randomized in two groups of 171 patients. The mean (SE) age was 30 years (0.9) vs 29 years (0.7), women, 103 (60.2%) vs 110 (64%), 81 (47.4%) never-smoked vs 83 (48.5%), and duration of asthma in years 16.0 (0.8) vs 16.6 (0.8) were no different in the combination vs salbutamol alone group, respectively. Likewise, there was no significant difference in asthma therapy received in the 24 h prior to presentation; most notably, 151 (88.3%) vs 153 (89.5%) received inhaled beta-agonists in that period. Baseline FEV(1) was 1.62 L (0.05 L) vs 1.53 L (0.03 L), and median time to treatment being received was no different between both groups, Both treatment arms improved significantly, The increase in FEV(1) in the combination group was 0.61 L (0.04 L) and in the salbutamol alone group was 0.52 L (0.04 L) at 90 min. There was a trend toward greater bronchodilatation in the combination group, but this did not reach statistical significance, Fewer hospitalizations, 5.9% vs 11.2%, occurred in the combination group, but this did not reach statistical significance. In, conclusion, this large multicenter study failed to show a significantly better response to a combination of salbutamol and ipratropium bromide vs salbutamol alone.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 16 条